Ohcanbohtosat - James Suh
- Čájehuvvo 1 - 20 / 26
- Sirdás čuovvovaš siidui
-
1
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma Dahkki Celina Ang, Samuel J. Klempner, Siraj M. Ali, Russell W. Madison, Jeffrey S. Ross, Eric A. Severson, David Fabrizio, Aaron M. Goodman, Razelle Kurzrock, James Suh, Sherri Z. Millis
Almmustuhtton 2019Artigo -
2
Genomic characterization of thymic epithelial tumors in a real-world dataset Dahkki Ken Kurokawa, Takehito Shukuya, R.A. Greenstein, Bünyamin Kaplan, Heather A. Wakelee, Jeffrey S. Ross, Katsuyuki Miura, Kazuyuki Furuta, Shumei Kato, James Suh, Smruthy Sivakumar, Ethan Sokol, David P. Carbone, Kazuhisa Takahashi
Almmustuhtton 2023Artigo -
3
Pulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections Dahkki James R. Gill, Zong‐Mei Sheng, Susan F. Ely, Donald G. Guinee, Mary Beth Beasley, James Suh, Charuhas Deshpande, Daniel J. Mollura, David M. Morens, Mike Bray, William D. Travis, Jeffery K. Taubenberger
Almmustuhtton 2010Artigo -
4
Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May... Dahkki James Suh, Adrienne Johnson, Lee A. Albacker, Kai Wang, Juliann Chmielecki, Garrett M. Frampton, Laurie M. Gay, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross
Almmustuhtton 2016Artigo -
5
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis Dahkki Ryan J. Hartmaier, Lee A. Albacker, Juliann Chmielecki, Mark Bailey, Jie He, Michael E. Goldberg, Shakti Ramkissoon, James Suh, Julia A. Elvin, Samuel Chiacchia, Garrett M. Frampton, Jeffrey S. Ross, Vincent A. Miller, Philip J. Stephens, Doron Lipson
Almmustuhtton 2017Artigo -
6
Nonamplification <i>ERBB2</i> genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies Dahkki Jeffrey S. Ross, Laurie M. Gay, Kai Wang, Siraj M. Ali, Saranya Chumsri, Julia A. Elvin, Ron Bose, Jo‐Anne Vergilio, James Suh, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Stanley E. Waintraub, Brian Leyland‐Jones, Vincent A. Miller, Philip J. Stephens
Almmustuhtton 2016Artigo -
7
HER2 V659 and G660 transmembrane mutations that stabilize homo- and hetero-dimerization are rare oncogenic drivers in lung adenocarcinoma that are clinically responsive to afatinib Dahkki S.-H.I. Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Charbel Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, J.S. Ross, P. Stephens, V.A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti
Almmustuhtton 2016Artigo -
8
Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy Dahkki Siraj M. Ali, Ming Yao, Jicheng Yao, Jing Wang, Yu‐Wei Cheng, Alexa B. Schrock, Gung‐Wei Chirn, Hui Chen, Shuo Mu, Laurie M. Gay, Julia A. Elvin, James Suh, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross, Kai Wang
Almmustuhtton 2017Artigo -
9
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i> Dahkki Jeffrey S. Ross, Marwan Fakih, Siraj M. Ali, Julia A. Elvin, Alexa B. Schrock, James Suh, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, James Sun, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay
Almmustuhtton 2018Artigo -
10
Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options Dahkki Laurie M. Gay, Sungeun Kim, Kyle Fedorchak, Madappa N. Kundranda, Yazmín Odia, Chaitali Nangia, James Battiste, Gerardo Colón‐Otero, Steven Powell, Jeffery S. Russell, Julia A. Elvin, Jo-Anne Vergilio, James Suh, Siraj M. Ali, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross
Almmustuhtton 2017Artigo -
11
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers Dahkki Aatur D. Singhi, Ben George, Joel Greenbowe, Jon Chung, James Suh, Anirban Maitra, Samuel J. Klempner, Andrew Hendifar, Javle Milind, Talia Golan, Randall E. Brand, Amer H. Zureikat, Somak Roy, Alexa B. Schrock, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali, Nathan Bahary
Almmustuhtton 2019Artigo -
12
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib Dahkki Sai‐Hong Ignatius Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Carolina Kawamura Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti
Almmustuhtton 2016Artigo -
13
Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies Dahkki Jeffrey S. Ross, Laurie M. Gay, K. Wang, Jo‐Anne Vergilio, James Suh, Shakti Ramkissoon, Hilary Somerset, Jennifer M. Johnson, Jeffery S. Russell, Siraj M. Ali, Alexa B. Schrock, David Fabrizio, Garrett M. Frampton, V.A. Miller, Philip J. Stephens, Julia A. Elvin, Daniel W. Bowles
Almmustuhtton 2017Artigo -
14
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations Dahkki Alexa B. Schrock, Garrett M. Frampton, James Suh, Zachary R. Chalmers, Mark R. Rosenzweig, Rachel Erlich, Balázs Halmos, Jonathan W. Goldman, Patrick M. Forde, Kurt Leuenberger, Nir Peled, Gregory P. Kalemkerian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Sai‐Hong Ignatius Ou
Almmustuhtton 2016Artigo -
15
Inactivation of Capicua drives cancer metastasis Dahkki Ross A. Okimoto, Frank Breitenbuecher, Victor Olivas, Wei Wu, Beatrice Gini, Matan Hofree, Saurabh Asthana, Gorjan Hrustanovic, Jennifer C. Flanagan, Asmin Tulpule, Collin M. Blakely, Henry J. Haringsma, Andrew D. Simmons, Kyle Gowen, James Suh, Vincent A. Miller, Siraj M. Ali, Martin Schüler, Trever G. Bivona
Almmustuhtton 2016Artigo -
16
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies Dahkki Rami N. Al‐Rohil, Ashley J. Tarasen, J. Andrew Carlson, Kai Wang, Adrienne Johnson, Roman Yelensky, Doron Lipson, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, James Suh, Vincent A. Miller, Philip J. Stephens, Prasanth Ganesan, Filip Janků, Daniel D. Karp, Vivek Subbiah, Martín C. Mihm, Jeffrey S. Ross
Almmustuhtton 2015Artigo -
17
<i>ALK</i>Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy Dahkki Jeffrey S. Ross, Siraj M. Ali, Omotayo Fasan, Jared Block, Sumanta K. Pal, Julia A. Elvin, Alexa B. Schrock, James Suh, Sahar Nozad, Sungeun Kim, Hwajeong Lee, Christine E. Sheehan, David Jones, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, V. A. Miller, Philip J. Stephens, Laurie M. Gay
Almmustuhtton 2017Artigo -
18
Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes Dahkki Jon Chung, Eric M. Sanford, Adrienne Johnson, Samuel J. Klempner, Alexa B. Schrock, Norma Alonzo Palma, Rachel Erlich, Garrett M. Frampton, Zachary R. Chalmers, Jo‐Anne Vergilio, Douglas A. Rubinson, Jiayi Sun, Juliann Chmielecki, Roman Yelensky, James Suh, Doron Lipson, Thomas J. George, Julia A. Elvin, Philip J. Stephens, V.A. Miller, Jeffrey S. Ross, Siraj M. Ali
Almmustuhtton 2016Artigo -
19
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling Dahkki Alexa B. Schrock, Shuyu Dan Li, Garrett M. Frampton, James Suh, Eduardo Braun, Ranee Mehra, Steven C. Buck, José A. Bufill, Nir Peled, Nagla Abdel Karim, Kuang-Yang Hsieh, Manuel I. Doria, James A. Knost, Rong Chen, Sai‐Hong Ignatius Ou, Jeffrey S. Ross, Philip J. Stephens, Paul A. S. Fishkin, Vincent A. Miller, Siraj M. Ali, Balázs Halmos, Jane J. Liu
Almmustuhtton 2017Artigo -
20
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra Dahkki Juliann Chmielecki, Mark Bailey, Jie He, Julia A. Elvin, Jo‐Anne Vergilio, Shakti Ramkissoon, James Suh, Garrett M. Frampton, James Sun, Samantha Morley, Daniel Spritz, Siraj M. Ali, Laurie M. Gay, Rachel Erlich, Jeffrey S. Ross, Joana Buxhaku, Hilary Davies‐Kershaw, Vinny Faso, Alexis Germain, Blair Glanville, Vincent A. Miller, Philip J. Stephens, Katherine A. Janeway, John M. Maris, Soheil Meshinchi, Trevor J. Pugh, Jack F. Shern, Doron Lipson
Almmustuhtton 2017Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Medicine
Cancer research
Cancer
Gene
Genetics
Internal medicine
Oncology
Lung cancer
KRAS
Adenocarcinoma
CDKN2A
Colorectal cancer
Mutation
Pathology
Targeted therapy
Allele
Chromosome
Computational biology
Epidermal growth factor receptor
Exon
Genome
Microsatellite
Microsatellite instability
ROS1
Bioinformatics
Breast cancer
Copy-number variation
Crizotinib
Fluorescence in situ hybridization